EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Labor Issues/Antitrust/Workplace LBR

HR. 1204--Pharmacies Antitrust Carve-out Legislation

Contacted: Food & Drug Administration (FDA); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office; Federal Trade Commission (FTC)

Bills named: H.R. 1204 (111th)

Defense DEF

H.R. 806, Mail Order Demonstration program for TRICARE Items related to implementing federal ceiling prices for prescription drugs dispensed at retail within the TRICARE program. H.R. 5013, the IMPROVE Acquisition Act HR 5136/S 3280, National Defense Authorization Act of 2011 (Section 700 CHAMPUS issues)

Contacted: Federal Trade Commission (FTC); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5136 (111th), H.R. 806 (111th), H.R. 5013 (111th)

Medicare/Medicaid MMM

Exclusion of specialty distributors' prompt pay discounts from the definition of averages sales price Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap, drug copay waivers. Reform proposals that impact Medicaid such as statutory changes to average manufacture price. General regulatory changes to the Medicare Part D program.

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); SENATE

Pharmacy PHA

Items related to reverse settlement payments between manufacturers--HR 1706, S 369; Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489; Regulatory design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements; Policies related to restricting PBMS' ability to manage prescription drug benefits-- HR 4199; PBM Audit Reform & Transparency Act--HR 5234.

Contacted: Food & Drug Administration (FDA); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); White House Office; HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1706 (111th), H.R. 4489 (111th), H.R. 5234 (111th), H.R. 4199 (111th)

Health Issues HCR

Regulatory policies related to health reform, structure, PBM and drug benefits--HR 3590, HR 4872 Establishment of a regulatory pathway for biogenerics/biosimilars--HR 3590 Regulatory implementation issues of HITECH (ARRA, HR 1)

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); White House Office; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Congressional Budget Office (CBO)

Bills named: H.R. 1 (111th), H.R. 3590 (111th), H.R. 4872 (111th)